The Turnbull government will spend more than $1 billion to make breakthrough hepatitis C cures available to all as part of an ambitious new plan to eradicate the deadly disease within a generation.
Health Minister Sussan Ley will announce the major new Pharmaceutical Benefits Scheme listing on Sunday, in a move that will give Australia's 230,000 hepatitis C sufferers affordable access to the drugs.
The drugs can currently cost patients up to $100,000. Under the subsidy, they will be available for the normal PBS co-payment of $37.70 for general patients and $6.10 for concessional patients.
Labels: australia, HCV